Robert Thomas

Non-Executive Director / Clarity Pharmaceuticals

Robert Thomas has more than 40 years of experience in the securities industry. He is chair of Starpharma Holdings, Aus Bio and Grahger Retail Securities. Mr Thomas is also a director of O’Connell Street Associates, REVA Medical, and Biotron. He was previously a director of Heartware International. Mr Thomas has a Bachelor of Economics from Monash University. He has been a member of the Securities Institute of Australia since 1976 and was appointed as a Fellow to the Institute in 1997. He is a Master Stockbroker and a Fellow of the Institute of Company Directors.

Lists and Charts

Roles

2013

Non-Executive Director, Chair since 2014

Starpharma Holdings

2012

Non-Executive Director

Biotron

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
1810^th	Blue Star Helium	-82.5%	-11.65%
1811^th	Green Technology Metals	-82.68%	0%
1812^th	Biotron	-82.69%	-21.82%
1813^th	GreenTech Metals	-83.01%	0%
1814^th	TG Metals	-83.03%	0%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

	NEW ROLE: Non-Executive Director, Clarity Pharmaceuticals	07 Apr 2022
	NEW ROLE: Non-Executive Director, Chair since 2014, Starpharma Holdings	03 Nov 2020
	REMUNERATION UPDATE: Non-Executive Director, Biotron	03 Nov 2020

Related Information

Access to our data for Robert Thomas is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Robert Thomas is linked to 4 organisations which are included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.